Printer Friendly

BIOPLASTY, INC. ANNOUNCES PROHIBITION OF SPIN OFF RECOMMENDED

 BIOPLASTY, INC. ANNOUNCES PROHIBITION OF SPIN OFF RECOMMENDED
 ST. PAUL, Minn., Sept. 1 /PRNewswire/ -- Bioplasty, Inc. (NASDAQ-NMS: BIOP) announced today that a United States Magistrate Judge has recommended that Bioplasty be prohibited from spinning off shares of its subsidiary, Uroplasty, Inc., unless it first posts a bond.
 The Report and Recommendation of the Honorable Floyd E. Boline, filed on Aug. 28, 1992, although not binding on the parties, and subject to objections by the parties, must be considered a set-back to Bioplasty's current efforts to spin off Uroplasty in its present form. If United States District Judge David Doty accepts the recommendation of Boline, and if Bioplasty does not post a bond, Bioplasty would not be able to complete the proposed spin off of Uroplasty in its present form until its litigation with certain shareholders alleging securities law violation had been settled or completed.
 Bioplasty previously announced the formation of Uroplasty, Inc. as a wholly owned subsidiary, the transfer to Uroplasty of certain urological and other assets, and the proposed distribution of shares of Uroplasty to shareholders of Bioplasty (a transaction known as a "spin off"). Bioplasty, Inc. and its wholly owned subsidiary may, however, continue its normal course of operations concentrating on the development and introduction of Macroplastique(TM) Implants.
 Bioplasty intends to submit to Doty its objections to the Magistrate Judge's Report.
 Bioplasty, Inc. has more than 21 years of experience in the development, manufacturing and marketing of plastic surgery products worldwide. Bioplasty's common stock is currently traded on NASDAQ National Market System under the symbol "BIOP."
 -0- 9/1/92
 /CONTACT: Timothy P. Lawin, president and chief executive officer, or Donald A. Major, vice president of Finance, 612-636-4112, both of Bioplasty/
 (BIOP) CO: Bioplasty, Inc.; Uroplasty, Inc. ST: Minnesota IN: MTC SU:


AL -- MN013 -- 5581 09/01/92 16:17 EDT
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Sep 1, 1992
Words:304
Previous Article:FLORIDA REGIONAL STOCK REPORT FOR TUESDAY, SEPT. 22
Next Article:ROCHESTER ADSTAR PROVIDES MAJOR STORAGE PRODUCTS FOR RISC/6000, AS/400 AND IBM PERSONAL COMPUTER COMPANY
Topics:


Related Articles
BIOPLASTY ANNOUNCES APPOINTMENT OF LINDA ALEXANDER TO THE POSITION OF DIRECTOR OF REGULATORY AFFAIRS
BIOPLASTY LICENSES SYNTHETIC WOUND CARE DRESSING
BIOPLASTY ANNOUNCES SECOND QUARTER RESULTS OF OPERATIONS
BIOPLASTY ANNOUNCES RESIGNATION OF CHIEF EXECUTIVE OFFICER AND CHAIRMAN OF THE BOARD
BIOPLASTY AGREES TO PROPOSED SETTLEMENT OF SHAREHOLDERS' SUIT
BIOPLASTY ANNOUNCES APPROVAL OF MERGER WITH BIO-MANUFACTURING
BIOPLASTY SETTLES PATENT INFRINGEMENT SUIT
BIOPLASTY SETTLES PATENT INFRINGEMENT SUIT
BIOPLASTY, INC. ANNOUNCES RESIGNATION OF PRESIDENT AND CHIEF EXECUTIVE OFFICER
BIOPLASTY, INC. REACHES TENTATIVE AGREEMENT TO SETTLE SHAREHOLDERS' SUIT

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters